Clinical Trials Directory

Trials / Completed

CompletedNCT00518609

Prevention of Infection in Indian Neonates - Phase I Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,326 (actual)
Sponsor
NICHD Global Network for Women's and Children's Health · Network
Sex
All
Age
60 Days
Healthy volunteers
Accepted

Summary

India, with one of the world's largest populations, continues to struggle with extremely high infant and neonatal mortality rates. Neonatal infection (sepsis) now accounts for 50 percent of deaths among community-born (and 20 percent of mortality among hospital-born) infants. This study is the first phase of a multi-phase project investigating interventions to prevent neonatal infection in India.

Detailed description

Invasive bacterial infections encompass clinical diagnoses of septicemia, pneumonia, and meningitis. Together, these infections are termed "neonatal sepsis" and account for over half of the newborn deaths at the district and sub-district level in India. Sepsis is the most common (80-90 percent) primary diagnosis for admission in Indian hospitals. Phase 1 of this study is a prospective, epidemiologic study involving over 1,000 community-based and hospital populations of newborn infants. It includes identifying all infants born in study hospitals and those brought to the hospitals with suspected sepsis; obtaining blood cultures from these infants and identifying the sepsis-causing bacteria; screening of all bacterial strains isolated from blood cultures for antimicrobial resistance; collecting basic demographic, risk factor, and treatment data on each case; and developing a computer-based system/network for data management. A village-level surveillance system was put in place to identify women during their pregnancy; monitor pregnancy outcomes; and establish a mechanism for referral of all potentially septic infants to participating clinics or hospitals for evaluation, including the collection of blood cultures. Potential sources of bacteria causing sepsis will be identified using molecular epidemiologic techniques. This involves matching septic infants' blood isolates with other colonizing isolates obtained from screening skin, throat, and stool cultures in the infant and skin and vaginal cultures from their mothers.

Conditions

Timeline

Start date
2003-07-01
Completion
2006-07-01
First posted
2007-08-21
Last updated
2014-07-31

Locations

3 sites across 1 country: India

Source: ClinicalTrials.gov record NCT00518609. Inclusion in this directory is not an endorsement.